Stay updated on Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new build or UI update.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe latest entry in the study record history shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a new release label for the page, updating the version history without altering study data or visible content.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study history now shows the latest revision as v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record history shows that recruitment has ended (no longer looking for participants). It also updates the revision tag to v3.6.0 and removes the previous v3.5.5 tag to reflect the latest history.SummaryDifference0.3%

- Check58 days agoChange DetectedThe record history now shows a new revision labeled v3.5.5, indicating a minor update to the page; the prior revision v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now includes a new revision entry: v3.5.4. The previous revision v3.5.3 is removed, reflecting a minor update to the page's version-tracking data.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.